CGM + Sinque · a behavioral read

A sensor gives you a moment.
Sinque gives you the story.

The first CGM built to read behavior, not biology — paired with continuous, day-to-day monitoring in Sinque. Fourteen days to discover who your patient really is. Then months of watching for what changes, early enough to act on it.

◆ Discovery · the 14-day read◆ Continuity · always-on◆ Behavior you coach · biology you refer

Discovery · 14 daysCGM · high-resolution

Continuity · ongoingSinque · always-on

CGM reads.Sinque remembers.

The shift

Medicine measures biology beautifully. Behavior stays invisible.

Blood pressure, HbA1c, weight, a hundred lab values — all tell you what's happening inside the body. But obesity isn't only biological. It's a behavioral disease with biological consequences.

And behavior has always been the hardest thing to see, because the only instrument we had was memory: what did you eat, did you move, how did you sleep? Nobody's lying. Human memory is simply a poor sensor.

So we changed the question — from “is the glucose healthy?” to “what did the patient do?”

Every meal, every late-night snack, every walk after dinner, every skipped breakfast leaves a fingerprint on glucose — objective, involuntary, timestamped, impossible to unconsciously edit. The body remembers what the patient forgot.

The usual question — a dead end

“Is this spike healthy? Is she pre-diabetic?”

In people without diabetes, CGM has no validated cut-offs — and given the same report, specialists disagree on who even needs follow-up. As a diagnostic in this population, it stalls.

Our question — a whole new signal

“What did this person actually do?”

When did they eat, skip, walk, stay up? That question glucose answers superbly — and it turns a weak diagnostic into the closest thing to behavioral ground truth a professional can hold.

We read glucose to learn what a person did.

✦

Roche's report is made for the medical staff — rigorous, complete, clinical, and it stays exactly that. Our reading keeps the same science, but it speaks to the health professional and the coach: it reminds them, in plain words, of everything the patient forgot to say.

Two roles, one relay

CGM reads. Sinque remembers.

They aren't two products you choose between. They're a relay — one runs the first leg with precision, then hands the baton to the other, which carries it the rest of the way. One is intense and brief. The other is light and endless.

The start · discovery

CGM — the short calibration

Role: A short, high-resolution read of who this person is
Answers: “What did this patient do these 14 days?”
Duration: ~14 days, then removed
The patient: Runs quietly in the background — nothing to track

The continuity · monitoring

Sinque — the long view

Role: The light, always-on daily monitoring
Answers: “What is this patient doing over months?”
Duration: Continuous, indefinitely
The patient: Lives in it, seamlessly, every day

Calibrate

CGM reads 14 days — the behavioral baseline.

Translate

The report turns glucose into behavior Sinque can hold.

Monitor

Sinque keeps watch against that baseline — continuous and low-cost — for months.

Recalibrate

Sinque flags real change — triggering the next short wear.

The middle stage is the one people overlook, and it's the most important. Between the sensor and the long view sits a translation — the reports that turn raw glucose into behavior the platform can carry and a professional can act on. Without it, the sensor's insight dies the day it comes off.

The GLP-1 catch

On GLP-1s, the danger flips — and behavior is where you catch it.

These drugs work. But the failure mode inverts: from over-eating to under-eating — skipped meals, too little protein, and muscle lost along with the fat.

The old failure mode

Eating too much

→

The GLP-1 failure mode

Eating too little

Weight loss still reads as success.

A flat, low glucose rhythm tells a different story. Weight congratulates under-fueling; behavior catches it. Catching it early isn't a nice-to-have — it's a genuine, differentiated safety contribution in the GLP-1 era, and exactly what a behavioral read is built to surface.

Built for the professional, not the chart

Sentences first. Numbers when you want them.

A busy professional should read the meaning in seconds. If they ever have to interpret a chart to use the tool, the tool has failed. So the read opens in plain language — and the math waits one click deeper.

Robert Redford

14-day read · 29 Oct – 11 Nov 2025 · reviewed today

✓ Verified

Behavior you coach

☀️The day runs flat and low — steady daytime responses, no big swings after meals. A calm baseline to build from.
🌙The lowest readings land overnight, in the small hours, on several nights. Worth talking about evening meals and how the nights feel.
🌅Mornings start low and pick up slowly. A gentle place to check whether breakfast is doing its job.

Suggested first conversation

The days look settled; the thing to look at together is the nights. A good moment to talk about evening fuelling and sleep.

A sample read — what the professional opens. Plain sentences first, each with a gentle nudge for the conversation; the numbers wait one click deeper.

✎

Behavioral language, not glycemic

We never ask a coach to think in glucose. Same reality, framed as behavior they can reason about.

“Expect high postprandial excursions”“Expect large responses after meals”

☀

The sun shows rhythm; the words hold meaning

A neutral picture of when the body was busiest — never “up = good.” Two identical suns can earn very different sentences, because the words carry the meaning.

◱

Deep model, simple surface

Tables and daily graphs still exist — demoted behind a toggle, not deleted. We simplified the report; we didn't throw away the math.

⇄

Framed as discovery, not correction

Every observation is something to explore — “a natural first place to start” — never a fault to fix. Change comes from learning something can be better, not from restriction.

Behavior you coach. Biology you refer.

The read stays with the coach — warm, plain, non-medical. When something looks like biology, we don't play doctor: we flag it calmly, name what we saw, never the condition, and refer it to the medical team with Roche's full report. Our reading translates glucose into behavior; Roche's report gives the doctor the biology. Neither tries to be the other.

☀

Behavior · you coach

Plain observations to act on directly. “Eating clusters late.” “Breakfast is skipped.” Most of the screen. Coaching, never diagnosis.

⚕

Biology · you refer

A calm, graded flag when a pattern deserves a clinician's eye. Names the observation and refers it to the medical team, with Roche's full report. A smaller, separate channel.

Where the evidence stands

We built for the use the evidence actually supports.

In people without diabetes, CGM isn't a diagnostic — and we don't pretend otherwise. What the evidence does support is CGM as a behavior-change and engagement tool. That's precisely what we built.

+7.4%

Across 25 RCTs and 2,996 participants, CGM feedback improved time-in-range and shifted diet behavior — with no proven weight effect. Behavior is where CGM earns its keep.

Meta-analysis, Int. J. Behavioral Nutrition & Physical Activity, 2024

~30%

Two people, the same standardized meal — very different glucose responses, with genetics explaining only about a third. The individual signature is real, and CGM reveals it.

ZOE PREDICT 1, Nature Medicine, 2020 · n=1,002

~6 hrs

On tirzepatide, patients reached 91% time-in-range — roughly six more hours a day in range than on basal insulin. GLP-1 therapy reshapes the very rhythm we read.

SURPASS-3 CGM substudy, Lancet Diabetes & Endocrinology

15%

Some “normoglycemic” people spend up to 15% of the day in prediabetic range — dynamic patterns the standard snapshot tests miss entirely.

Stanford “glucotypes,” Hall et al., PLOS Biology, 2018

ⓘThe honest version: there are no validated diagnostic cut-offs for non-diabetic CGM, and even specialists interpret the same report differently. That's exactly why we don't diagnose with it — we read it for behavior, and refer anything medical to a clinician.

The whole idea, in one breath

We're not a weight company. We're not a CGM company. We're the predictive behavioral layer of obesity care.

Earlier intervention. Safer GLP-1 care. And coaching that finally has objective behavioral ground truth to stand on.

A better tomorrow — in view today.

Not a medical device. CGM is used here as a non-medical behavioral assessment with escalation to a clinician — it is not a diagnostic device. Ew2health · Sinque + Roche · concept for professional review.

A sensor gives you a moment.Sinque gives you the story.